Topical indomethacin for vernal keratoconjunctivitis
Seema Gupta, Ashi Khurana, B. K. Ahluwalia, Nitin Gupta
Abstract
Seema Gupta, Ashi Khurana, B. K. Ahluwalia, Nitin Gupta
Abstract
Twenty-five patients with vernal keratoconjunctivitis (VKC) were treated with 1% indomethacin eyedrops and were followed for 5 weeks. Apart from 4 patients all of them showed marked improvement. The possible mechanism of the role of indomethacin in VKC is discussed.
OpenAlex reports 15 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Twenty-five patients with vernal keratoconjunctivitis (VKC) were treated with 1% indomethacin eyedrops and were followed for 5 weeks. Apart from 4 patients all of them showed marked improvement. The possible mechanism of the role of indomethacin in VKC is discussed.
Key concepts: Vernal keratoconjunctivitis, Keratoconjunctivitis, Medicine, Ophthalmology, Dermatology, Allergic conjunctivitis, KERATOCONJUNCTIVITIS SICCA, Internal medicine